Over 40% of participants treated with EFX 50mg for 96 weeks, compared with 0% for placebo, showed regression of liver fibrosis by all of three ...

Akero Therapeutics (AKRO) announced results of analyses supporting the clinical activity of efruxifermin in metabolic dysfunction-associated ...

SAN DIEGO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology ...

College of the Canyons will host a Science, Technology, Engineering, and Mathematics (STEM) Speaker Series on Friday, ...

Velotric, a rapid leader in the e-bike market, renowned for their effortlessly comfortable e-bikes with their ComfortMax technology that deliver outstanding performance, top-tier safety, and a ...

On track to report topline data from Phase 2 TRANQUILITY trial in first half of 2025 – – Assembled Cardiovascular Scientific Advisory Board (CV SAB), comprised of leading academic and industry experts ...

The First International Congress of Graduates of the Latin American School of Medicine (ELAM) concludes today, marking the ...

Communication is key to a well-functioning school environment, and posters play a vital role in spreading information ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Greetings! And welcome to the DURECT Corporation Third Quarter ...

The awards, hosted by the Department for Business and Trade (DBT), provide a unique opportunity to unearth the most promising ...

The annual “Cellulose Fibres Conference”, will return in 2025 with an expanded focus to address challenges and explore how ...